Market Cap 5.18M
Revenue (ttm) 0.00
Net Income (ttm) -12.88M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 12,021,100
Avg Vol 1,469,020
Day's Range N/A - N/A
Shares Out 708,000.00
Stochastic %K 72%
Beta 1.04
Analysts Hold
Price Target $18.00

Company Profile

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of cancer-related anorexia; and ART12.11, a cocrystal composition of cannabidiol and tetramethylpyrazine for the treatment anxiety, depression, post...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 925 7049
Address:
505 Lomas Santa Fe, Suite 160, Solana Beach, United States
ReversalTrack
ReversalTrack Mar. 21 at 6:40 PM
JAGU✅ uranium+rare earth play, Keep this high on watch for next week. JAGU sits right in the middle of: •⚛️ Energy crisis (uranium) •🛰️ Defense tech (rare earths) •🌍 Geopolitical supply shift -The world is entering a resource war and most people still don’t see it Critical minerals uranium and rare earths are now essential for defense energy AI and every advanced system the future depend -Uranium and rare earths are needed in the war and in all things needed in the future, and the US will be flooding billions into South America, exactly where jaguar is.JAGU sitting right where the money is going. US pushing billions into critical minerals in Latin America Argentina becoming a key supply hub And JAGU already has exposure there… Rare earth + uranium + IPO reset = serious setup. $CCTG $BIAF $ARTL $CURV good list ./1
0 · Reply
Porto98
Porto98 Mar. 21 at 4:27 PM
$ARTL Artelo Biosciences, Inc. is registering up to 1,641,587 shares of common stock or pre-funded warrants, plus placement agent warrants for 131,327 shares and up to 1,772,914 underlying shares, in a best efforts primary offering. The securities are priced off an assumed public offering price of $7.31 per share. Assuming all securities are sold at that price, Artelo estimates net proceeds of about $10.8 million, which it plans to use for working capital and general corporate purposes. Shares outstanding would rise to 2,377,714 from 736,127 as of March 18, 2026, leading to immediate and substantial dilution for new investors. The deal includes pre-funded warrants with a $0.001 exercise price and 4.99% or 9.99% beneficial ownership limits, and unlisted placement agent warrants. The company highlights significant risks, including Nasdaq listing compliance, the absence of a minimum raise in this best efforts structure, and the speculative nature and limited liquidity of the warrants.
0 · Reply
DonCorleone77
DonCorleone77 Mar. 21 at 1:45 PM
$ARTL Artelo Biosciences files to sell 1.64M shares of common stock
0 · Reply
LongBallBarn
LongBallBarn Mar. 21 at 12:20 PM
$ARTL $AMTD $EPOW $PRSO Monster adds for Monday $10K each
0 · Reply
LongBallBarn
LongBallBarn Mar. 21 at 11:27 AM
0 · Reply
TalkMarkets
TalkMarkets Mar. 21 at 2:21 AM
Stay Calm, This Too Shall Pass; Relative Strength Is Everything $AAMI $ACXP $ARTL $ASGN $BIAF https://talkmarkets.com/article/stay-calm-this-too-shall-pass-relative-strength-is-everything-1774058695
0 · Reply
BreakoutBullz
BreakoutBullz Mar. 21 at 12:16 AM
🛎️ Trade Recap 🛎️ $ANNA ran 🔥💰🎯 +60% from 4.90 call! $AZTR ran 🔥💰🎯 +58% from .24 call! $ARTL ran 🔥💰🎯 +55% from 6.30 initial call! $MNDR ran 🔥💰🎯 +31% from 1.05 call! $CODX ran 🔥💰🎯 +18% from 3.45 call!
0 · Reply
FORECAST_ONE
FORECAST_ONE Mar. 20 at 11:09 PM
You heard it here first! 🔥🟢💸 Phenomenal trade from early entries and guidance. Lets run in back monday! $ANNA $AZTR $RPGL $ARTL
1 · Reply
Peaceouty
Peaceouty Mar. 20 at 10:13 PM
$ARTL Sabby is probably involved, but they got unexpectedly squeezed today. So might pump it now to short it.
0 · Reply
Thebluesquiggly
Thebluesquiggly Mar. 20 at 10:11 PM
$ARTL Claude AI: What typically happens intraday with small-cap dilutive offerings like this: Initial drop of 15–30% is common on the day an S-1 like this is filed/announced 15% down from $7.64 = ~$6.50 30% down from $7.64 = ~$5.35 Given the severity here (123% share count increase, going concern, Nasdaq deadline pressure), the lower end of that range or worse is more plausible Additional downward factors specific to this situation: The stock has already been through a reverse split in March, meaning momentum traders are likely skittish Extremely thin float (736K shares pre-offering) means price moves can be violent in either direction "Best efforts" with no minimum means uncertainty lingers — the offering could partially close or fail entirely, which paradoxically can cause more selling
0 · Reply
Latest News on ARTL
Artelo Biosciences Announces Reverse Stock Split

Mar 6, 2026, 8:00 AM EST - 15 days ago

Artelo Biosciences Announces Reverse Stock Split


Artelo Biosciences Analyst See It As An Emerging Biotech

Jul 8, 2025, 3:06 PM EDT - 9 months ago

Artelo Biosciences Analyst See It As An Emerging Biotech


ReversalTrack
ReversalTrack Mar. 21 at 6:40 PM
JAGU✅ uranium+rare earth play, Keep this high on watch for next week. JAGU sits right in the middle of: •⚛️ Energy crisis (uranium) •🛰️ Defense tech (rare earths) •🌍 Geopolitical supply shift -The world is entering a resource war and most people still don’t see it Critical minerals uranium and rare earths are now essential for defense energy AI and every advanced system the future depend -Uranium and rare earths are needed in the war and in all things needed in the future, and the US will be flooding billions into South America, exactly where jaguar is.JAGU sitting right where the money is going. US pushing billions into critical minerals in Latin America Argentina becoming a key supply hub And JAGU already has exposure there… Rare earth + uranium + IPO reset = serious setup. $CCTG $BIAF $ARTL $CURV good list ./1
0 · Reply
Porto98
Porto98 Mar. 21 at 4:27 PM
$ARTL Artelo Biosciences, Inc. is registering up to 1,641,587 shares of common stock or pre-funded warrants, plus placement agent warrants for 131,327 shares and up to 1,772,914 underlying shares, in a best efforts primary offering. The securities are priced off an assumed public offering price of $7.31 per share. Assuming all securities are sold at that price, Artelo estimates net proceeds of about $10.8 million, which it plans to use for working capital and general corporate purposes. Shares outstanding would rise to 2,377,714 from 736,127 as of March 18, 2026, leading to immediate and substantial dilution for new investors. The deal includes pre-funded warrants with a $0.001 exercise price and 4.99% or 9.99% beneficial ownership limits, and unlisted placement agent warrants. The company highlights significant risks, including Nasdaq listing compliance, the absence of a minimum raise in this best efforts structure, and the speculative nature and limited liquidity of the warrants.
0 · Reply
DonCorleone77
DonCorleone77 Mar. 21 at 1:45 PM
$ARTL Artelo Biosciences files to sell 1.64M shares of common stock
0 · Reply
LongBallBarn
LongBallBarn Mar. 21 at 12:20 PM
$ARTL $AMTD $EPOW $PRSO Monster adds for Monday $10K each
0 · Reply
LongBallBarn
LongBallBarn Mar. 21 at 11:27 AM
0 · Reply
TalkMarkets
TalkMarkets Mar. 21 at 2:21 AM
Stay Calm, This Too Shall Pass; Relative Strength Is Everything $AAMI $ACXP $ARTL $ASGN $BIAF https://talkmarkets.com/article/stay-calm-this-too-shall-pass-relative-strength-is-everything-1774058695
0 · Reply
BreakoutBullz
BreakoutBullz Mar. 21 at 12:16 AM
🛎️ Trade Recap 🛎️ $ANNA ran 🔥💰🎯 +60% from 4.90 call! $AZTR ran 🔥💰🎯 +58% from .24 call! $ARTL ran 🔥💰🎯 +55% from 6.30 initial call! $MNDR ran 🔥💰🎯 +31% from 1.05 call! $CODX ran 🔥💰🎯 +18% from 3.45 call!
0 · Reply
FORECAST_ONE
FORECAST_ONE Mar. 20 at 11:09 PM
You heard it here first! 🔥🟢💸 Phenomenal trade from early entries and guidance. Lets run in back monday! $ANNA $AZTR $RPGL $ARTL
1 · Reply
Peaceouty
Peaceouty Mar. 20 at 10:13 PM
$ARTL Sabby is probably involved, but they got unexpectedly squeezed today. So might pump it now to short it.
0 · Reply
Thebluesquiggly
Thebluesquiggly Mar. 20 at 10:11 PM
$ARTL Claude AI: What typically happens intraday with small-cap dilutive offerings like this: Initial drop of 15–30% is common on the day an S-1 like this is filed/announced 15% down from $7.64 = ~$6.50 30% down from $7.64 = ~$5.35 Given the severity here (123% share count increase, going concern, Nasdaq deadline pressure), the lower end of that range or worse is more plausible Additional downward factors specific to this situation: The stock has already been through a reverse split in March, meaning momentum traders are likely skittish Extremely thin float (736K shares pre-offering) means price moves can be violent in either direction "Best efforts" with no minimum means uncertainty lingers — the offering could partially close or fail entirely, which paradoxically can cause more selling
0 · Reply
Thebluesquiggly
Thebluesquiggly Mar. 20 at 10:09 PM
$ARTL Claude AI: Based purely on the mechanics of what's in this filing, here's my honest analytical estimate: Most likely range: $4.50 – $6.00 within the trading day Here's the reasoning: The floor anchors: The offering price of $7.31 is the immediate ceiling pressure — anyone can (in theory) get shares at $7.31, so why pay $7.64? Post-offering book value per share works out to ~$3.24 per the prospectus The midpoint between current price and book value lands around $5.00–5.50
1 · Reply
Thebluesquiggly
Thebluesquiggly Mar. 20 at 10:06 PM
$ARTL claude: The auditor issued a going concern warning They have a March 30, 2026 deadline from Nasdaq to fix their stockholders' equity deficiency — this offering is essentially a last-ditch attempt to cure that There is also an ELOC (equity line) for up to $25M (expandable to $50M) that could add further dilution beyond this offering Bottom line: This offering is being done under extreme pressure — 10 days before a Nasdaq delisting deadline — at a discount to market, more than doubling the share count. That is significant downward pressure on the price. The fact that it's trading at $7.64 vs. the $7.31 offering price is a spread that will likely compress quickly once the market fully absorbs this filing.
0 · Reply
Thebluesquiggly
Thebluesquiggly Mar. 20 at 10:06 PM
$ARTL Cluade: This is a primary offering — Artelo itself is raising new capital. Here's what it actually says: What this offering really is: Artelo is offering 1,641,587 new shares (or pre-funded warrants) at an assumed price of $7.31/share (the March 18 close) That's a ~123% increase in shares outstanding, from 736,127 to 2,377,714 Maximum net proceeds to the company: ~$10.8 million (after the 8% placement agent fee and ~$140K in expenses) Placement agent (Craft Capital Management) also gets warrants for 8% of shares sold, at $7.31/share Why this is highly bearish at $7.64: The offering price is set at $7.31 , meaning new investors are being offered shares cheaper than market Dilution per share to new buyers is $4.07 (per the prospectus itself), meaning the post-offering book value per share would be ~$3.24 There is no minimum close — they can raise any amount or nothing The company had only $600K cash vs. $4M+ in current liabilities as of Dec 31, 2025
0 · Reply
Peaceouty
Peaceouty Mar. 20 at 9:48 PM
$ARTL prefunded warrants to be exact.
0 · Reply
Peaceouty
Peaceouty Mar. 20 at 9:45 PM
$ARTL Offering + warrants.. GTFO
1 · Reply
Thebluesquiggly
Thebluesquiggly Mar. 20 at 9:43 PM
$ARTL https://www.sec.gov/Archives/edgar/data/1621221/000164033426000502/artl_s1.htm
0 · Reply
TeamPheonix
TeamPheonix Mar. 20 at 8:15 PM
Called you $WNW for +576% profits! Now I am calling you very early on $ARBB for a massive run. ARBB is starting its big run and only has 900k share float. Make sure to be early on ARBB if you want to catch the potential 300% move. . $BIAF $LNAI $ARTL
0 · Reply
TurdSniper
TurdSniper Mar. 20 at 8:01 PM
$ARTL Damn nice drop on this turd ⬇💩
0 · Reply
GSP
GSP Mar. 20 at 7:59 PM
0 · Reply
Habib1234
Habib1234 Mar. 20 at 7:50 PM
0 · Reply
GSP
GSP Mar. 20 at 7:50 PM
Nasty day for $SPY and these were all long ideas we traded today. Stock selection and A+ setups are everything. $ANNA $EDSA $ARTL .
0 · Reply
LBTheEmcee
LBTheEmcee Mar. 20 at 7:48 PM
$ARTL hits 8.50 and drops right back down yet we get one red candle and it sells off all day
0 · Reply